NCT04818190 is a NA clinical trial of Sensory neurotization in Sensitisation, sponsored by University of Manitoba.

Who is sponsoring NCT04818190?

NCT04818190 is sponsored by University of Manitoba.

What drugs are being tested in NCT04818190?

Interventions in NCT04818190: Sensory neurotization.

What condition does NCT04818190 study?

NCT04818190 studies Sensitisation.

Is NCT04818190 still recruiting?

NCT04818190 is currently status unknown. Last updated 4 October 2021.

Last reviewed 2021-10-04 · How we verify

NCT04818190

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

DIEP (Deep Inferior Epigastric Artery Perforator) Flap Sensory Recovery Following Neurotization

Status unknown NA Last updated 4 October 2021

What this trial tests

NA trial testing Sensory neurotization in Sensitisation in 30 participants. Status unknown.

Timeline

1 September 2021

Primary endpoint
1 April 2023

1 May 2023

Quick facts

Lead sponsor	University of Manitoba
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	single group
Masking	double
Primary purpose	treatment
Enrollment	30
Start date	1 September 2021
Primary completion	1 April 2023
Estimated completion	1 May 2023
Sites	1 location across Canada

Drugs / interventions tested

Sensory neurotization

Conditions studied

Sensitisation — all drugs for Sensitisation →

Sponsor

University of Manitoba

Who can join

18 and older, female only, with Sensitisation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to compare the sensory return of DIEP flaps with nerve connection to DIEP flaps with no nerve connection to see which is better. This research is being done because the presence of sensation in a reconstructed breast has been shown to improve patient-related quality of life following mastectomy reconstruction and is an important safety factor for prevention of burns and other flap injuries. Unfortunately, women who have breast skin excised during mastectomy are reconstructed with a traditional DIEP flap that does not restore sensation to the skin.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other University of Manitoba trials

Trials by the same sponsor.

NCT07528417 — Evaluation of Antibiotic Prophylaxis in Myelodysplastic Syndromes and Acute Myeloid Leukemia (MYELO-CAN:ABX) · Phase 2 · not yet recruiting
NCT07366515 — Feasibility of a Multimodal Virtual Reality Intervention to Reduce Preoperative Anxiety in Cancer Surgery Patients · NA · not yet recruiting
NCT07354386 — Effects of Dried Whole Fruits on Metabolism in Diabetes · NA · enrolling by invitation
NCT07361315 — Development and Online Evaluation of an Online Course for Parasomnias · NA · recruiting
NCT07023744 — CANnabinoids for Drug Resistant Epilepsy (DRE) in Adults and Children · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04818190 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Manitoba
Last refreshed: 4 October 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04818190.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing